Prospective Connectomic-Based Deep Brain Stimulation Programming for Parkinson's Disease

Overview

Journal Mov Disord

Date 2024 Oct 21

PMID 39431498

Authors

Kevin Hines

Angela M Noecker

Anneke M Frankemolle-Gilbert

Tsao-Wei Liang

Jeffrey Ratliff

Melissa Heiry

Cameron C McIntyre

Chengyuan Wu

Affiliations

Soon will be listed here.

Abstract

Background: Efficacy of deep brain stimulation (DBS) relies on accurate lead placement as well as optimization of the stimulation parameters. Although clinical software tools are now available, programming still largely relies on a monopolar review, a tedious process for both patients and programmers.

Objective: This study investigates the safety and feasibility of prospective automated connectomic DBS programming (automated connectomic programming [ACP]), focusing on the recruitment of specific white matter pathways.

Methods: After DBS implantation, a detailed connectomic DBS model in patient-specific space was developed for each study participant. A driving-force model was used to quantify pathway recruitment across 2400 different DBS settings. Optimization algorithms maximized recruitment of therapeutic pathways while minimizing recruitment of side-effect pathways. Thirteen subjects were enrolled in two study phases that compared DBS settings derived from ACP to standard clinical DBS settings.

Results: Nine patients underwent reprogramming with ACP (5 globus pallidus interna [GPi], 4 subthalamic nucleus [STN]). Four patients underwent initial programming with ACP (3 GPi, 1 STN). All patients tolerated ACP without persistent side effects. In the reprogramming cohort, 3 patients preferred their ACP program, and 1 patient felt it was comparable to their clinical program. Unified Parkinson's Disease Rating Scale, Part III, scores for the initial ACP cohort (3 GPi, 1 STN) improved by an average of 43.5% (40.4-52.6 ± 5.6%).

Conclusions: ACP appeared clinically safe and feasible. It provided reasonable motor improvement, which can be further optimized with subsequent clinical adjustment. Additional investigation is required to refine the optimization algorithm and to quantify the clinical benefit of ACP in a larger cohort. © 2024 International Parkinson and Movement Disorder Society.

References

Miller C, Muller J, Noecker A, Matias C, Alizadeh M, McIntyre C . Automatic Segmentation of Parkinson Disease Therapeutic Targets Using Nonlinear Registration and Clinical MR Imaging: Comparison of Methodology, Presence of Disease, and Quality Control. Stereotact Funct Neurosurg. 2023; 101(2):146-157. DOI: 10.1159/000526719. View

Noecker A, Frankemolle-Gilbert A, Howell B, Petersen M, Beylergil S, Shaikh A . StimVision v2: Examples and Applications in Subthalamic Deep Brain Stimulation for Parkinson's Disease. Neuromodulation. 2021; 24(2):248-258. PMC: 8581744. DOI: 10.1111/ner.13350. View

Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R . Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010; 9(6):581-91. PMC: 2874872. DOI: 10.1016/S1474-4422(10)70093-4. View

Follett K, Weaver F, Stern M, Hur K, Harris C, Luo P . Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010; 362(22):2077-91. DOI: 10.1056/NEJMoa0907083. View

Merola A, Romagnolo A, Krishna V, Pallavaram S, Carcieri S, Goetz S . Current Directions in Deep Brain Stimulation for Parkinson's Disease-Directing Current to Maximize Clinical Benefit. Neurol Ther. 2020; 9(1):25-41. PMC: 7229063. DOI: 10.1007/s40120-020-00181-9. View

Waldthaler J, Bopp M, Kuhn N, Bacara B, Keuler M, Gjorgjevski M . Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease. Brain Stimul. 2021; 14(5):1109-1117. DOI: 10.1016/j.brs.2021.07.064. View

Kestenbaum M, Ford B, Louis E . Estimating the Proportion of Essential Tremor and Parkinson's Disease Patients Undergoing Deep Brain Stimulation Surgery: Five-Year Data From Columbia University Medical Center (2009-2014). Mov Disord Clin Pract. 2017; 2(4):384-387. PMC: 5571873. DOI: 10.1002/mdc3.12185. View

van Wijk B, Alkemade A, Forstmann B . Functional segregation and integration within the human subthalamic nucleus from a micro- and meso-level perspective. Cortex. 2020; 131:103-113. DOI: 10.1016/j.cortex.2020.07.004. View

Bower K, Noecker A, Frankemolle-Gilbert A, McIntyre C . Model-Based Analysis of Pathway Recruitment During Subthalamic Deep Brain Stimulation. Neuromodulation. 2023; 27(3):455-463. PMC: 10598236. DOI: 10.1016/j.neurom.2023.02.084. View

10.

Frankemolle-Gilbert A, Howell B, Bower K, Veltink P, Heida T, McIntyre C . Comparison of methodologies for modeling directional deep brain stimulation electrodes. PLoS One. 2021; 16(12):e0260162. PMC: 8673613. DOI: 10.1371/journal.pone.0260162. View

11.

Pauli W, Nili A, Michael Tyszka J . A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei. Sci Data. 2018; 5:180063. PMC: 5903366. DOI: 10.1038/sdata.2018.63. View

12.

Wong J, Viswanathan V, Nozile-Firth K, Eisinger R, Leone E, Desai A . STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson's Disease. Front Hum Neurosci. 2020; 14:578615. PMC: 7651783. DOI: 10.3389/fnhum.2020.578615. View

13.

Bingham C, McIntyre C . Subthalamic deep brain stimulation of an anatomically detailed model of the human hyperdirect pathway. J Neurophysiol. 2022; 127(5):1209-1220. PMC: 9054256. DOI: 10.1152/jn.00004.2022. View

14.

Horn A, Reich M, Vorwerk J, Li N, Wenzel G, Fang Q . Connectivity Predicts deep brain stimulation outcome in Parkinson disease. Ann Neurol. 2017; 82(1):67-78. PMC: 5880678. DOI: 10.1002/ana.24974. View

15.

McClelland 3rd S, Ford B, Senatus P, Winfield L, Du Y, Pullman S . Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy. Neurosurg Focus. 2006; 19(5):E12. View

16.

Akram H, Sotiropoulos S, Jbabdi S, Georgiev D, Mahlknecht P, Hyam J . Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease. Neuroimage. 2017; 158:332-345. PMC: 6581538. DOI: 10.1016/j.neuroimage.2017.07.012. View

17.

McIntyre C, Anderson R . Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation. J Neurochem. 2016; 139 Suppl 1:338-345. PMC: 5358920. DOI: 10.1111/jnc.13649. View

18.

Okun M, Tagliati M, Pourfar M, Fernandez H, Rodriguez R, Alterman R . Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005; 62(8):1250-5. DOI: 10.1001/archneur.62.8.noc40425. View

19.

Fayed I, Syed M, Gingold E, Alizadeh M, Sharan A, Wu C . A Novel and Simple Method Using Computed Tomography Streak Artifact to Determine the Orientation of Directional Deep Brain Stimulation Leads. Neurosurgery. 2023; 93(5):1036-1045. DOI: 10.1227/neu.0000000000002536. View

20.

Kurtis M, Rajah T, Delgado L, Dafsari H . The effect of deep brain stimulation on the non-motor symptoms of Parkinson's disease: a critical review of the current evidence. NPJ Parkinsons Dis. 2017; 3:16024. PMC: 5516616. DOI: 10.1038/npjparkd.2016.24. View